Document Detail


Generics, Supergenerics and Patent Strategies--SMi's 13th Annual Meeting.
MedLine Citation:
PMID:  20582864     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
SMi's 13th Annual Meeting on Generics, Supergenerics and Patent Strategies, held in London, included topics covering new trends in the generics field, the difficulties faced by companies in entering the generics market and recent developments in IP. This conference report highlights selected presentations on generics in India, protecting pharmaceutical products in China, changes in generics law and litigation in the US and Europe, challenges for market selection and entry for generics companies, the influence of changes in the healthcare market on the generics industry, supergenerics, and biosimilars.
Authors:
Catherine Edwards
Related Documents :
22587294 - Lin and goldman reply:.
22167384 - Opt-out donation and tacit consent: a reply to wilkinson and de wispelaere.
15630464 - Is it ethical to use enhancement technologies to make us better than well?
3631344 - Psychotherapy in a changing postindustrial society.
4938244 - Thiopropazate hydrochloride in persistent dyskinesia.
22306644 - Reforming the law concerning assisted dying.
Publication Detail:
Type:  Congresses    
Journal Detail:
Title:  IDrugs : the investigational drugs journal     Volume:  13     ISSN:  2040-3410     ISO Abbreviation:  IDrugs     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-28     Completed Date:  2010-10-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883655     Medline TA:  IDrugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  433-6     Citation Subset:  IM    
Affiliation:
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. cathy.edwards@thomsonreuters.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Products / economics
China
Delivery of Health Care / trends
Drug Industry / legislation & jurisprudence,  trends*
Drugs, Generic* / economics
European Union
Humans
India
Marketing / economics,  trends
Patents as Topic*
Therapeutic Equivalency
United States
Chemical
Reg. No./Substance:
0/Biological Products; 0/Drugs, Generic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association for Research in Vision and Ophthalmology (ARVO) - 2010 Annual Meeting. For Sight: The Fu...
Next Document:  Vaccine Manufacturing - Second Annual visiongain Conference.